When to Cervical Abnormalities
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Different Influences of Endometriosis and Pelvic Inflammatory Disease On
International Journal of Environmental Research and Public Health Article Different Influences of Endometriosis and Pelvic Inflammatory Disease on the Occurrence of Ovarian Cancer Jing-Yang Huang 1,2,†, Shun-Fa Yang 1,2 , Pei-Ju Wu 1,3,†, Chun-Hao Wang 4,†, Chih-Hsin Tang 5,6,7 and Po-Hui Wang 1,2,3,8,* 1 Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan; [email protected] (J.-Y.H.); [email protected] (S.-F.Y.); [email protected] (P.-J.W.) 2 Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan 3 Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 402, Taiwan 4 Department of Medicine, National Taiwan University, Taipei 106, Taiwan; [email protected] 5 School of Medicine, China Medical University, Taichung 404, Taiwan; [email protected] 6 Chinese Medicine Research Center, China Medical University, Taichung 404, Taiwan 7 Department of Medical Laboratory Science and Biotechnology, College of Medical and Health Science, Asia University, Taichung 413, Taiwan 8 School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan * Correspondence: [email protected] † Equal contributions as first authors. Abstract: To compare the rate and risk of ovarian cancer in patients with endometriosis or pelvic inflammatory disease (PID). A nationwide population cohort research compared the risk of ovarian cancer in 135,236 age-matched comparison females, 114,726 PID patients, and 20,510 endometriosis patients out of 982,495 females between 1 January 2002 and 31 December 2014 and ended on the date Citation: Huang, J.-Y.; Yang, S.-F.; of confirmation of ovarian cancer, death, or 31 December 2014. -
Sexually Transmitted Infections DST-1007 Mucopurulent Cervicitis (MPC)
Certified Practice Area: Reproductive Health: Sexually Transmitted Infections DST-1007 Mucopurulent Cervicitis (MPC) DST-1007 Mucopurulent Cervicitis (MPC) DEFINITION Inflammation of the cervix with mucopurulent or purulent discharge from the cervical os. POTENTIAL CAUSES Bacterial: • Chlamydia trachomatis (CT) • Neisserria gonorrhoeae (GC) Viral: • herpes simplex virus (HSV) Protozoan: • Trichomonas vaginalis (TV) Non-STI: • chemical irritants • vaginal douching • persistent disruption of vaginal flora PREDISPOSING RISK FACTORS • sexual contact where there is transmission through the exchange of body fluids • sexual contact with at least one partner • sexual contact with someone with confirmed positive laboratory test for STI • incomplete STI medication treatment • previous STI TYPICAL FINDINGS Sexual Health History • may be asymptomatic • sexual contact with at least one partner • increased abnormal vaginal discharge • dyspareunia • bleeding after sex or between menstrual cycles • external or internal genital lesions may be present with HSV infection • sexual contact with someone with confirmed positive laboratory test for STI Physical Assessment Cardinal Signs • mucopurulent discharge from the cervical os (thick yellow or green pus) and /or friability of the cervix (sustained bleeding after swabbing gently) BCCNM-certified nurses (RN(C)s) are responsible for ensuring they reference the most current DSTs, exercise independent clinical judgment and use evidence to support competent, ethical care. NNPBC January 2021. For more information or to provide feedback on this or any other decision support tool, email mailto:[email protected] Certified Practice Area: Reproductive Health: Sexually Transmitted Infections DST-1007 Mucopurulent Cervicitis (MPC) The following may also be present: • abnormal change in vaginal discharge • cervical erythema/edema Other Signs • cervicitis associated with HSV infection: o cervical lesions usually present o may have external genital lesions with swollen inguinal nodes Notes: 1. -
Fitz-Hugh–Curtis Syndrome
Gynecol Surg (2011) 8:129–134 DOI 10.1007/s10397-010-0642-8 REVIEW ARTICLE Fitz-Hugh–Curtis syndrome Ch. P. Theofanakis & A. V. Kyriakidis Received: 25 October 2010 /Accepted: 14 November 2010 /Published online: 7 December 2010 # Springer-Verlag 2010 Abstract Fitz-Hugh–Curtis syndrome is characterized by Background perihepatic inflammation appearing with pelvic inflamma- tory disease (PID), mostly in women of childbearing age. The Fitz-Hugh–Curtis syndrome, perihepatitis associated Acute pain and tenderness in the right upper abdomen is the with pelvic inflammatory disease (PID) [1], was first most common symptom that makes women visit the described by Carlos Stajano in 1920 to the Society of emergency rooms. It can also emerge with fever, nausea, Obstetricians and Gynecologists of Montevideo in Uruguay vomiting, and, in fewer cases, pain in the left upper [2]. Ten years later, in 1930, Thomas Fitz-Hugh and Arthur abdomen. It seems that the pathogens that are mostly Curtis took the description of the syndrome one step further responsible for this situation is Chlamydia trachomatis and by connecting the acute clinical syndrome of right upper Neisseria gonorrhoeae. Because of its characteristics, quadrant pain due to pelvic infection with the “violin- differential diagnosis for this syndrome is a constant, as it string” adhesions (Fig. 1) present in women with signs of mimics many known diseases, such as cholelithiasis, prior salpingitis [3, 4]. After having studied several cases of cholecystitis, and pulmonary embolism. The development patients with gonococcal disease, baring these adhesions of CT scanning provided diagnosticians with a very useful between the liver and the abdominal wall, Curtis demon- tool in the process of recognizing and analyzing the strated a couple of years later that these signs are absent in syndrome. -
Understanding Endometriosis - Information Pack
Understanding Endometriosis - Information Pack What is endometriosis? Endometriosis (pronounced en- doh – mee – tree – oh – sis) is the name given to the condition where cells like the ones in the lining of the womb (uterus) are found elsewhere in the body. Every month a woman’s body goes through hormonal changes. Hormones are naturally released which cause the lining of the womb to increase in preparation for a fertilized egg. If pregnancy does not occur, this lining will break down and bleed – this is then released from the body as a period. Endometriosis cells react in the same way – except that they are located outside the womb. During the monthly cycle hormones stimulate the endometriosis, causing it to grow, then break down and bleed. This internal bleeding, unlike a period, has no way of leaving the body. This leads to inflammation, pain, and the formation of scar tissue (adhesions). Endometriosis is not an infection. Endometrial tissue can also be found in the ovary, Endometriosis is not contagious. where it can form cysts, called ‘chocolate cysts’ Endometriosis is not cancer. because of their appearance. Endometriosis is most commonly found inside the pelvis, around the ovaries, the fallopian tubes, on the outside of the womb or the ligaments (which hold the womb in place), or the area between your rectum and your womb, called the Pouch of Douglas. It can also be found on the bowel, the bladder, the intestines, the vagina and the rectum. You can also have endometrial tissue that grows in the muscle layer of the wall of the womb (this is another condition called adenomyosis). -
Chlamydia Trachomatis: an Important Sexually Transmitted Disease in Adolescents and Young Adults
Chlamydia Trachomatis: An Important Sexually Transmitted Disease in Adolescents and Young Adults Donald E. Greydanus, MD, and Elizabeth R. McAnarney, MD Rochester, New York Chlamydia trachomatis is being recognized as an important sexually transmitted disease in adolescents and young adults. This report reviews the recent literature regarding the many clinical entities encompassed by this organism; this includes urethritis and cervicitis as well as epididymitis, salpingitis, peritonitis, perihepatitis, urethral syndrome, Reiter syndrome, arthritis, endocarditis, and others. It is emphasized that many aspects of chlamydial infections parallel those of gonorrhea, including incidence, transmission, carrier state, reservoir, complications, (local and systemic), and others. A paragonococcal spectrum of sexual chlamydial disorders is discussed as well as effective antibiotic therapy. This micro biological agent must always be considered if venereal disease is suspected by the clinician in teenagers or adults. Mixed infections with Chlamydia trachomatis and Neisseria gonor- rhoeae are common in both males and females. It may be preferable to treat gonorrhea with tetracycline to cover for this possibility. Recent reviews1-3 have implicated Chlamydia ically distinct, causing “nonspecific” urethritis or trachomatis as a major cause of sexually transmit cervicitis, trachoma, and lymphogranuloma vene ted disease (STD) in young adult and presumably reum). adolescent populations in the Western world. The Chlamydia trachomatis infections have been -
Prevention of Salpingitis by a Chlamydia Eradication Control Effort Background
PREVENTION OF INFERTILITY SOURCE DOCUMENT PREVENTION OF SALPINGITIS BY A CHLAMYDIA ERADICATION CONTROL EFFORT BACKGROUND Chlamydia trachomatis causes about 4 to 5 million infections annually in the U.S.1 Since chlamydia became a reportable disease in the U.S. in 1986, the number of cases in both men and women have increased each year to current rates of 290/100,000 women and 52/100,000 men in 19951. The greater number of reported cases in women than men reflects more widespread screening for chlamydia in women than men and the increase in rates also probably reflect increased screening over this time. The prevalence of chlamydia infection is highest for sexually active women aged 15-21 and declines thereafter. However, based upon serum antibody to chlamydia, women continue to become infected until about age 30 at which time the prevalence of chlamydial antibody plateaus at about 50%. The prevalence of chlamydia infection has ranged widely from 3 to 5% in asymptomatic women to over 20% in women seen in sexually transmitted disease (STD) clinics2. Chlamydia causes well-defined symptomatic infections of the mucosal surfaces of the urethra, cervix, endometrium and fallopian tubes. However, most women with chlamydia have infections at these sites that produce non-specific symptoms or, commonly, no symptoms. It has been demonstrated repeatedly that sexually active populations where little diagnostic testing and specific treatment is being used, the prevalence of infection can reach very high levels because chlamydia is so often asymptomatic. DIAGNOSIS OF CHLAMYDIA Considerable advance has occurred in diagnostic tests for C. trachomatis in the past decade. -
Differential Diagnosis of Endometriosis by Ultrasound
diagnostics Review Differential Diagnosis of Endometriosis by Ultrasound: A Rising Challenge Marco Scioscia 1 , Bruna A. Virgilio 1, Antonio Simone Laganà 2,* , Tommaso Bernardini 1, Nicola Fattizzi 1, Manuela Neri 3,4 and Stefano Guerriero 3,4 1 Department of Obstetrics and Gynecology, Policlinico Hospital, 35031 Abano Terme, PD, Italy; [email protected] (M.S.); [email protected] (B.A.V.); [email protected] (T.B.); [email protected] (N.F.) 2 Department of Obstetrics and Gynecology, “Filippo Del Ponte” Hospital, University of Insubria, 21100 Varese, VA, Italy 3 Obstetrics and Gynecology, University of Cagliari, 09124 Cagliari, CA, Italy; [email protected] (M.N.); [email protected] (S.G.) 4 Department of Obstetrics and Gynecology, Azienda Ospedaliero Universitaria, Policlinico Universitario Duilio Casula, 09045 Monserrato, CA, Italy * Correspondence: [email protected] Received: 6 October 2020; Accepted: 15 October 2020; Published: 20 October 2020 Abstract: Ultrasound is an effective tool to detect and characterize endometriosis lesions. Variances in endometriosis lesions’ appearance and distorted anatomy secondary to adhesions and fibrosis present as major difficulties during the complete sonographic evaluation of pelvic endometriosis. Currently, differential diagnosis of endometriosis to distinguish it from other diseases represents the hardest challenge and affects subsequent treatment. Several gynecological and non-gynecological conditions can mimic deep-infiltrating endometriosis. For example, abdominopelvic endometriosis may present as atypical lesions by ultrasound. Here, we present an overview of benign and malignant diseases that may resemble endometriosis of the internal genitalia, bowels, bladder, ureter, peritoneum, retroperitoneum, as well as less common locations. An accurate diagnosis of endometriosis has significant clinical impact and is important for appropriate treatment. -
Women's Health
Women’s Health Kristen Jones, DO Osteopathic Faculty St. Luke’s Family Medicine Residency Bethlehem, PA ACOFP exam • Women’s Issues (4% of test – OB/GYN = 4%) between 4-6% • Common Topics • Vaginal Discharge • Pelvic Pain • Cancer risk factors • Menstrual disorders • Breast Discharge • Eang disorders • Osteoporosis • HRT • 23 yo with vaginal discharge. Sexually ac[ve. Pelvic exam reveals: • Thin gray-white discharge, pH 5, a strong fishy odor is present when KoH is added to the discharge. • A)Bacterial Vaginosis • B)Gonorrhea • C)Chlamydia • D)Candida • E)Physiologic Discharge • 23 yo with vaginal discharge. Sexually ac[ve. Pelvic exam reveals: • Thin gray-white discharge, pH 5, a strong fishy odor is present when KoH is added to the discharge. • A)Bacterial Vaginosis • B)Gonorrhea • C)Chlamydia • D)Candida • E)Physiologic Discharge Bacterial Vaginosis • pH >4.5 • +Whiff Test • +Clue cells – epithelial cells with adherent bacteria. • Caused by Gardnerella • Treat with Flagyl 500mg po q12hx7 days (safe in pregnancy) • 23 yo with vaginal discharge. Sexually ac[ve. Pelvic exam reveals: • pH <4, vulvar erythema, thick white discharge • Most likely cause is: • A)Bacterial Vaginosis • B)Trichomonas • C)Chlamydia • D)Candida • E)Physiologic Discharge • 23 yo with vaginal discharge. Sexually ac[ve. Pelvic exam reveals: • pH <4.5, vulvar erythema, thick white discharge • Most likely cause is: • A)Bacterial Vaginosis • B)Trichomonas • C)Chlamydia • D)Candida • E)Physiologic Discharge Vaginal Candidiasis • pH <4.5 • Budding yeast and hyphae on KOH • Thick white, chunky discharge • Vulvar erythema and pruri[s • Treat with PO fluconazole 150mg po x1 • Treat with PV clotrimazole or miconazole for 7 days during pregnancy • 23 yo with vaginal discharge. -
Update on Treatment of Menstrual Disorders
THE REPRODUCTIVE YEARS Update on treatment of menstrual disorders Martha Hickey and Cynthia M Farquhar DISTURBANCES OF MENSTRUAL BLEEDING are a major social and medical problem for women, their families and ABSTRACT the health services, and a common reason for women to ■ There is evidence from well designed randomised controlled consult their general practitioners or gynaecologists. In the trials that modern medical and conservative surgical United Kingdom, each year one in 20 women consult their therapies (including endometrial ablation) are effective GPs aboutThe Medical heavy Journal menstrual of Australia bleeding. ISSN:1 0025-729X 16 June treatments for heavy menstrual bleeding for many women. Heavy2003 bleeding178 12 625-629 is the most common menstrual com- ■ Submucous fibroids may be resected directly via the plaint.©The In Medicalmost cases,Journal thisof Australia has no 2003 identifiable www.mja.com.au pelvic or The reproductive years hysteroscope, reducing menstrual bleeding, although data systemic cause and is termed dysfunctional uterine bleed- are available only from case series. ing. Irregular dysfunctional uterine bleeding is generally ■ associated with anovulation. Historically, many women with Endometriosis is common, may also occur in young women heavy menstrual bleeding were advised to undergo hysterec- and may present with atypical or non-cyclical symptoms; tomy, which was the only way of ensuring a “cure”. conservative laparoscopic surgery increases fecundity and However, a range of new and effective interventions can now reduces dysmenorrhoea and dyspareunia. be offered for dysfunctional uterine bleeding and other ■ Randomised trials of the levonorgestrel intrauterine system common causes of menstrual disorder, such as fibroids and in women with menorrhagia have shown that hysterectomy endometriosis. -
Vaginitis and Cervicitis in the Clinic 2009.Pdf
in the clinic Vaginitis and Cervicitis Prevention page ITC3-2 Screening page ITC3-3 Diagnosis page ITC3-5 Treatment page ITC3-10 Practice Improvement page ITC3-14 CME Questions page ITC3-16 Section Co-Editors: The content of In the Clinic is drawn from the clinical information and Christine Laine, MD, MPH education resources of the American College of Physicians (ACP), including Sankey Williams, MD PIER (Physicians’ Information and Education Resource) and MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine Science Writer: editors develop In the Clinic from these primary sources in collaboration with Jennifer F. Wilson the ACP’s Medical Education and Publishing Division and with the assistance of science writers and physician writers. Editorial consultants from PIER and MKSAP provide expert review of the content. Readers who are interested in these primary resources for more detail can consult http://pier.acponline.org and other resources referenced in each issue of In the Clinic. CME Objective: To gain knowledge about the management of patients with vagini- tis and cervicitis. The information contained herein should never be used as a substitute for clinical judgment. © 2009 American College of Physicians in the clinic he vagina has a squamous epithelium and is susceptible to bacterial vaginosis, trichomoniasis, and candidiasis. Vaginitis may also result Tfrom irritants, allergic reactions, or postmenopausal atrophy. The endocervix has a columnar epithelium and is susceptible to infection with Neisseria gonorrhoeae, Chlamydia trachomatis, or less commonly, herpes sim- plex virus. Vaginitis causes discomfort, but rarely has serious consequences except during pregnancy and gynecologic surgery. Cervicitis may be asymptomatic and if untreated, can lead to pelvic inflammatory disease (PID), which can damage the reproductive organs and lead to infertility, ectopic pregnancy, or chronic pelvic pain. -
Intricate Connections Between the Microbiota and Endometriosis
International Journal of Molecular Sciences Review Intricate Connections between the Microbiota and Endometriosis Irene Jiang, Paul J. Yong, Catherine Allaire and Mohamed A. Bedaiwy * Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of British Columbia, D415A-4500 Oak Street, Vancouver, BC V6H 3N1, Canada; [email protected] (I.J.); [email protected] (P.J.Y.); [email protected] (C.A.) * Correspondence: [email protected]; Tel.: +604-875-2000 (ext. 4310) Abstract: Imbalances in gut and reproductive tract microbiota composition, known as dysbiosis, disrupt normal immune function, leading to the elevation of proinflammatory cytokines, compro- mised immunosurveillance and altered immune cell profiles, all of which may contribute to the pathogenesis of endometriosis. Over time, this immune dysregulation can progress into a chronic state of inflammation, creating an environment conducive to increased adhesion and angiogenesis, which may drive the vicious cycle of endometriosis onset and progression. Recent studies have demonstrated both the ability of endometriosis to induce microbiota changes, and the ability of antibiotics to treat endometriosis. Endometriotic microbiotas have been consistently associated with diminished Lactobacillus dominance, as well as the elevated abundance of bacterial vaginosis-related bacteria and other opportunistic pathogens. Possible explanations for the implications of dysbiosis in endometriosis include the Bacterial Contamination Theory and immune activation, cytokine- impaired gut function, altered estrogen metabolism and signaling, and aberrant progenitor and stem-cell homeostasis. Although preliminary, antibiotic and probiotic treatments have demonstrated efficacy in treating endometriosis, and female reproductive tract (FRT) microbiota sampling has Citation: Jiang, I.; Yong, P.J.; Allaire, successfully predicted disease risk and stage. -
Pelvic Inflammatory Disease: the Importance of Aggressive Treatment in Adolescents
REVIEW ELLEN S. ROME, MD, MPH Head, Section of Adolescent Medicine, Cleveland Clinic; Assistant Professor, Ohio State University School of Medicine; Clinical Instructor, Case Western Reserve University School of Medicine. Pelvic inflammatory disease: The importance of aggressive treatment in adolescents ABSTRACT ELVIC INFLAMMATORY DISEASE (PID) causes more morbidity in young women Pelvic inflammatory disease (PID), an infection of the of reproductive age than all other serious infec- female genital tract, presents a number of difficult tions combined. Nonetheless, PID and its challenges in diagnosis and management. Adolescents in major sequelae of tubal scarring, chronic pelvic particular require aggressive care of PID to prevent the pain, and infertility are preventable if physi- long-term sequelae of chronic pelvic pain and infertility. cians diagnose it early and treat it aggressively. This article reviews the etiology, microbiology, diagnosis, Unfortunately, many young women, and and management of PID, with an emphasis on treating especially adolescents, delay seeking care and adolescents with PID. fail to comply with treatment. And, as the Centers for Disease Control and Prevention KEY POINTS noted in its 1998 Guidelines for the Treatment of Sexually Transmitted Diseases,1 many cases A recent study found that many clinicians were not of PID go undiagnosed because both patients following specific CDC recommendations for PID, such as and physicians fail to recognize the implica- those concerning hospitalization of adolescents. tions of mild, nonspecific symptoms. This article describes the diagnosis and Clinicians should consider the diagnosis of PID in any treatment of PID, with a special emphasis on adolescents, the age group most at risk.